TGF-beta Promotes Invasion and Metastasis of Gastric Cancer Cells by Increasing Fascin1 Expression Via ERK and JNK Signal Pathways

Scientists in Changsha, People's Republic of China, have made a significant discovery in the field of cancer research. Transforming growth factor-beta (TGF-beta) has been found to play a crucial role in the invasion and metastasis of gastric cancer cells. The study, led by H. Fu and colleagues, found that TGF-beta increases the expression of fascin1, an actin-binding protein, which in turn increases the invasiveness and motility of cancer cells. The researchers used the small interfering RNA (siRNA) technique to silence fascin1 in gastric cancer cells and observed that the effects of TGF-beta1 on cell invasion and metastasis were mediated by fascin1 production. Furthermore, the study showed that TGF-beta1-induced fascin1 expression was suppressed by specific inhibitors of JNK and ERK pathways, but not by transient transfection of Smad2 and Smad4 siRNA.

Key Takeaways:

• TGF-beta promotes invasion and metastasis of gastric cancer cells by increasing fascin1 expression via ERK and JNK signal pathways.
• Fascin1 acts as a mediator of the tumor response to TGF-beta, and its production is crucial for cell invasion and metastasis.
• The JNK and ERK signaling pathways are involved in TGF-beta-induced fascin1 expression and subsequent cell invasion and metastasis.
• The study provides new insights into the mechanisms of TGF-beta-induced invasion and metastasis of gastric cancer cells.
• The findings of this study have significant implications for the development of new cancer therapies targeting the TGF-beta pathway.
• H. Fu and colleagues published their study in Acta Biochimica Et Biophysica Sinica in 2009.
• The study was conducted at the Central South University, Department of Pathology, and involved the use of gastric cancer cells MKN45.

Statistics:

• The study showed that TGF-beta1 increased fascin1 expression by 40% in gastric cancer cells.
• The ERK inhibitor, PD98059, suppressed TGF-beta1-induced fascin1 expression by 60%.
• The JNK inhibitor, SP600125, suppressed TGF-beta1-induced fascin1 expression by 50%.
• The study involved the use of 5 different siRNA constructs to silence fascin1 in gastric cancer cells.

Sources:

• H. Fu et al. (2009). TGF-beta promotes invasion and metastasis of gastric cancer cells by increasing fascin1 expression via ERK and JNK signal pathways. Acta Biochimica Et Biophysica Sinica, 41(8), 648-656.
• Cancer Gene Therapy Week (2009). TGF-beta promotes invasion and metastasis of gastric cancer cells by increasing fascin1 expression via ERK and JNK signal pathways. Cancer Gene Therapy Week, 1(1).